Microsatellite instability and therapeutic consequences in colorectal cancer

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair defects was discovered in the last decade of the previous century. As a field of investigation which successfully joins basic and clinical science, MSI is an example of real translational science, starting from the molecular basis of a disease and extending to the clinical arena. In clinical settings, MSI is a diagnostic biomarker leading to the diagnosis of hereditary nonpolyposis colorectal cancer. However, the clinical implication of MSI testing extends to the role of prognostic marker, due to the better outcome of patients with MSI colorectal cancer. Additionally, MSI identified a general lack of response to neo-adjuvant therapy employing 5-fluorouracil. Like predictive markers of response to chemotherapy, the role of MSI is likely not exhausted, as chemotherapy regimens need to take into account the peculiar biological and clinical behavior of MSI cancers.

Original languageEnglish
Pages (from-to)304-309
Number of pages6
JournalDigestive Diseases
Volume30
Issue number3
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Microsatellite Instability
Colorectal Neoplasms
Therapeutics
Hereditary Nonpolyposis Colorectal Neoplasms
Drug Therapy
DNA Mismatch Repair
Fluorouracil
Biomarkers
Phenotype

Keywords

  • Colorectal cancer
  • Hereditary nonpolyposis colorectal cancer
  • Microsatellite instability

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Microsatellite instability and therapeutic consequences in colorectal cancer. / Laghi, Luigi; Malesci, Alberto.

In: Digestive Diseases, Vol. 30, No. 3, 06.2012, p. 304-309.

Research output: Contribution to journalArticle

@article{2381bbc6da2f48b191b0ef0e04f8ee56,
title = "Microsatellite instability and therapeutic consequences in colorectal cancer",
abstract = "Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair defects was discovered in the last decade of the previous century. As a field of investigation which successfully joins basic and clinical science, MSI is an example of real translational science, starting from the molecular basis of a disease and extending to the clinical arena. In clinical settings, MSI is a diagnostic biomarker leading to the diagnosis of hereditary nonpolyposis colorectal cancer. However, the clinical implication of MSI testing extends to the role of prognostic marker, due to the better outcome of patients with MSI colorectal cancer. Additionally, MSI identified a general lack of response to neo-adjuvant therapy employing 5-fluorouracil. Like predictive markers of response to chemotherapy, the role of MSI is likely not exhausted, as chemotherapy regimens need to take into account the peculiar biological and clinical behavior of MSI cancers.",
keywords = "Colorectal cancer, Hereditary nonpolyposis colorectal cancer, Microsatellite instability",
author = "Luigi Laghi and Alberto Malesci",
year = "2012",
month = "6",
doi = "10.1159/000337003",
language = "English",
volume = "30",
pages = "304--309",
journal = "Digestive Diseases",
issn = "0257-2753",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Microsatellite instability and therapeutic consequences in colorectal cancer

AU - Laghi, Luigi

AU - Malesci, Alberto

PY - 2012/6

Y1 - 2012/6

N2 - Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair defects was discovered in the last decade of the previous century. As a field of investigation which successfully joins basic and clinical science, MSI is an example of real translational science, starting from the molecular basis of a disease and extending to the clinical arena. In clinical settings, MSI is a diagnostic biomarker leading to the diagnosis of hereditary nonpolyposis colorectal cancer. However, the clinical implication of MSI testing extends to the role of prognostic marker, due to the better outcome of patients with MSI colorectal cancer. Additionally, MSI identified a general lack of response to neo-adjuvant therapy employing 5-fluorouracil. Like predictive markers of response to chemotherapy, the role of MSI is likely not exhausted, as chemotherapy regimens need to take into account the peculiar biological and clinical behavior of MSI cancers.

AB - Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair defects was discovered in the last decade of the previous century. As a field of investigation which successfully joins basic and clinical science, MSI is an example of real translational science, starting from the molecular basis of a disease and extending to the clinical arena. In clinical settings, MSI is a diagnostic biomarker leading to the diagnosis of hereditary nonpolyposis colorectal cancer. However, the clinical implication of MSI testing extends to the role of prognostic marker, due to the better outcome of patients with MSI colorectal cancer. Additionally, MSI identified a general lack of response to neo-adjuvant therapy employing 5-fluorouracil. Like predictive markers of response to chemotherapy, the role of MSI is likely not exhausted, as chemotherapy regimens need to take into account the peculiar biological and clinical behavior of MSI cancers.

KW - Colorectal cancer

KW - Hereditary nonpolyposis colorectal cancer

KW - Microsatellite instability

UR - http://www.scopus.com/inward/record.url?scp=84862889606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862889606&partnerID=8YFLogxK

U2 - 10.1159/000337003

DO - 10.1159/000337003

M3 - Article

C2 - 22722556

AN - SCOPUS:84862889606

VL - 30

SP - 304

EP - 309

JO - Digestive Diseases

JF - Digestive Diseases

SN - 0257-2753

IS - 3

ER -